Based on end of last Q and with today's infusion of cash, MITI now has on hand well over $100M. This should get the well down the road toward developing their drug platform.....
Micromet Closes $80.5 Million Public Offering of Common Stock
10:48 am ET 08/04/2009- PR Newswire
BETHESDA, Md., Aug. 4, /PRNewswire-FirstCall/ --Micromet, Inc. (Nasdaq: MITI) ("Micromet" or the "Company"), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced the closing of its previously announced public offering of 14,000,000 shares of common stock. Micromet also announced that the underwriters for the offering have exercised in full their over-allotment option to purchase an additional 2,100,000 shares, bringing the total shares sold to 16,100,000 at a price of $5.00 per share for gross proceeds of $80.5 million. The Company received net proceeds of approximately $75.0 million, after deducting underwriting discounts and estimated offering expenses. |
